1MED SA
Marco Minoia has a diverse background in project management and clinical operations across various industries, including healthcare and biotechnology. With a Ph.D in Molecular Microbiology, Marco has experience in evaluating potential for personalized nutrition, inhibition of gene transfer for antibiotic therapy, and ecological links between biodegradation and toxicity. Marco holds a Master's Degree in Business Administration and Bioentrepreneurship, along with a Master's Degree in Biotechnology. Currently serving as the Head of Clinical Operations (Interim) at 1MED SA, Marco has also held positions at companies such as Abich srl, Enantis s.r.o., and Tampere University. Additionally, Marco has co-founded a biotech company and has interned at DuPont Nutrition & Health.
1MED SA
1MED, is the leading European MedTech specialized solutions provider, offering end-to-end development expertise within the medical device, novel technology and combination products fields. Founded in 2014, with headquarter in Agno, Switzerland, and employing 100+ professionals across the Europe, 1MED's mission is to support all the MedTech organizations in facing the complexity associated with the development of innovative medical devices in compliance with MDR. Such support may include providing preclinical support, regulatory advice, clinical study management, post marketing support and quality management systems across the clinical research continuum with a cross-functional approach which led to win the certification and certification maintenance of more than 500 different medical devices in the last 2 years only. 1MED not only offers a broad range of internal competences, our clients in fact can trust on a preferred partners network and consolidated relationships with European Notified Bodies and Competent Authorities. There is much more to know about us! Please visit https://www.1med.ch/ to learn about the solutions we can offer or e-mail us: info@1med.ch